BR9507980A - Composto composição farmacêutica para uso no tratamento e/ou profilaxia de ansiedade mania depressão desordens associadas com uma hemorragia subaracnóide ou choke neural processo de tratamento e/ou profilaxia de ansiedade mania depressão desordens associadas com uma hemorragia subaracnóide ou choque neural composição farmacêutica uso de um composto - Google Patents
Composto composição farmacêutica para uso no tratamento e/ou profilaxia de ansiedade mania depressão desordens associadas com uma hemorragia subaracnóide ou choke neural processo de tratamento e/ou profilaxia de ansiedade mania depressão desordens associadas com uma hemorragia subaracnóide ou choque neural composição farmacêutica uso de um compostoInfo
- Publication number
- BR9507980A BR9507980A BR9507980A BR9507980A BR9507980A BR 9507980 A BR9507980 A BR 9507980A BR 9507980 A BR9507980 A BR 9507980A BR 9507980 A BR9507980 A BR 9507980A BR 9507980 A BR9507980 A BR 9507980A
- Authority
- BR
- Brazil
- Prior art keywords
- anxiety
- prophylaxis
- pharmaceutical composition
- compound
- disorders associated
- Prior art date
Links
- 208000019901 Anxiety disease Diseases 0.000 title 2
- 206010026749 Mania Diseases 0.000 title 2
- 208000032851 Subarachnoid Hemorrhage Diseases 0.000 title 2
- 230000036506 anxiety Effects 0.000 title 2
- 150000001875 compounds Chemical class 0.000 title 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 2
- 230000001537 neural effect Effects 0.000 title 2
- 239000008194 pharmaceutical composition Substances 0.000 title 2
- 238000011321 prophylaxis Methods 0.000 title 2
- 238000002635 electroconvulsive therapy Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 230000035939 shock Effects 0.000 title 1
- 238000011282 treatment Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
- C07D311/68—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with nitrogen atoms directly attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Pain & Pain Management (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Psychology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9411632A GB9411632D0 (en) | 1994-06-10 | 1994-06-10 | Novel treatment |
| GB9411798A GB9411798D0 (en) | 1994-06-13 | 1994-06-13 | Novel treatment |
| PCT/EP1995/002076 WO1995034545A1 (en) | 1994-06-10 | 1995-05-31 | Benzopyrans and their use as therapeutic agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9507980A true BR9507980A (pt) | 1997-08-12 |
Family
ID=26305044
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9507980A BR9507980A (pt) | 1994-06-10 | 1995-05-31 | Composto composição farmacêutica para uso no tratamento e/ou profilaxia de ansiedade mania depressão desordens associadas com uma hemorragia subaracnóide ou choke neural processo de tratamento e/ou profilaxia de ansiedade mania depressão desordens associadas com uma hemorragia subaracnóide ou choque neural composição farmacêutica uso de um composto |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US5760074A (pt) |
| EP (2) | EP0764157B1 (pt) |
| JP (2) | JP3575767B2 (pt) |
| KR (1) | KR100397721B1 (pt) |
| CN (2) | CN1174975C (pt) |
| AP (1) | AP714A (pt) |
| AT (2) | ATE211469T1 (pt) |
| AU (1) | AU701060B2 (pt) |
| BG (1) | BG63339B1 (pt) |
| BR (1) | BR9507980A (pt) |
| CA (1) | CA2192480C (pt) |
| CY (1) | CY2508B1 (pt) |
| CZ (1) | CZ286081B6 (pt) |
| DE (2) | DE69531801T2 (pt) |
| DK (2) | DK0764157T3 (pt) |
| ES (2) | ES2207590T3 (pt) |
| FI (1) | FI120686B (pt) |
| HK (1) | HK1039115B (pt) |
| HU (1) | HUT76136A (pt) |
| NO (1) | NO315651B1 (pt) |
| NZ (1) | NZ287872A (pt) |
| OA (1) | OA10593A (pt) |
| PL (1) | PL188134B1 (pt) |
| PT (2) | PT764157E (pt) |
| RO (1) | RO113463B1 (pt) |
| SG (1) | SG67930A1 (pt) |
| SI (2) | SI0764157T1 (pt) |
| SK (1) | SK281456B6 (pt) |
| WO (1) | WO1995034545A1 (pt) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20010021780A1 (en) * | 1992-12-11 | 2001-09-13 | Smithkline Beecham P.L.C. | Pharmaceutical composition containing bicyclic type compounds |
| GB9411635D0 (en) * | 1994-06-10 | 1994-08-03 | Smithkline Beecham Plc | Novel treatment |
| GB9619492D0 (en) * | 1996-09-18 | 1996-10-30 | Smithkline Beecham Plc | Novel treatment |
| US6492415B2 (en) * | 1996-09-18 | 2002-12-10 | Smithkline Beecham P.L.C. | Use of benzopyranols to treat neurological disorders |
| GB9726543D0 (en) * | 1997-12-16 | 1998-02-11 | Smithkline Beecham Plc | Novel compositions |
| GB9813949D0 (en) * | 1998-06-29 | 1998-08-26 | Smithkline Beecham Plc | Novel compounds |
| GB0028697D0 (en) * | 2000-11-23 | 2001-01-10 | S P A | Novel process |
| GEP20105001B (en) * | 2005-04-04 | 2010-06-10 | Takeda Pharmaceuticals Co | Preventive or remedy for depression or anxiety neurosis |
| JP2011522031A (ja) * | 2008-06-05 | 2011-07-28 | ミンスター・リサーチ・リミテッド | 新規な治療 |
| EP2307004A1 (en) * | 2008-06-05 | 2011-04-13 | Minster Research Limited | Novel treatments |
| RU2012124837A (ru) * | 2009-12-03 | 2014-01-10 | Проксимэджен ЛТД | Лечение аллодинии и гипералгезии |
| CN102770134A (zh) | 2009-12-03 | 2012-11-07 | 普罗克西梅根有限公司 | 传染性失调的治疗 |
| US20140011773A1 (en) | 2012-07-03 | 2014-01-09 | Proximagen Limited | Pro-drug Compounds |
| GB201304814D0 (en) * | 2013-03-15 | 2013-05-01 | Proximagen Ltd | Pro-drug compounds |
| GB201322932D0 (en) * | 2013-12-23 | 2014-02-12 | Proximagen Ltd | Pro-drug compounds |
| GB201322934D0 (en) | 2013-12-23 | 2014-02-12 | Proximagen Ltd | Prodrug compounds |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3479726D1 (de) * | 1983-05-18 | 1989-10-19 | Beecham Group Plc | Benzopyran derivatives. |
| GB9112721D0 (en) * | 1991-06-13 | 1991-07-31 | Smithkline Beecham Plc | Novel treatment |
| DK0673374T3 (da) * | 1992-12-11 | 2000-07-31 | Smithkline Beecham Corp | Farmaceutisk præparat, der indeholder bicykliske forbindelsestyper |
| JPH08505132A (ja) * | 1992-12-11 | 1996-06-04 | スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー | 医薬活性を有する二環式化合物 |
| US5536718A (en) * | 1995-01-17 | 1996-07-16 | American Cyanamid Company | Tricyclic benzazepine vasopressin antagonists |
-
1995
- 1995-05-31 DK DK95921798T patent/DK0764157T3/da active
- 1995-05-31 SK SK1587-96A patent/SK281456B6/sk not_active IP Right Cessation
- 1995-05-31 AU AU26727/95A patent/AU701060B2/en not_active Expired
- 1995-05-31 EP EP95921798A patent/EP0764157B1/en not_active Expired - Lifetime
- 1995-05-31 CZ CZ19963617A patent/CZ286081B6/cs not_active IP Right Cessation
- 1995-05-31 DK DK01200801T patent/DK1114821T3/da active
- 1995-05-31 SI SI9530579T patent/SI0764157T1/xx unknown
- 1995-05-31 NZ NZ287872A patent/NZ287872A/en not_active IP Right Cessation
- 1995-05-31 CN CNB951944134A patent/CN1174975C/zh not_active Expired - Lifetime
- 1995-05-31 AT AT95921798T patent/ATE211469T1/de active
- 1995-05-31 PT PT95921798T patent/PT764157E/pt unknown
- 1995-05-31 AT AT01200801T patent/ATE250052T1/de active
- 1995-05-31 HU HU9603415A patent/HUT76136A/hu not_active Application Discontinuation
- 1995-05-31 CA CA002192480A patent/CA2192480C/en not_active Expired - Lifetime
- 1995-05-31 SG SG1996008495A patent/SG67930A1/en unknown
- 1995-05-31 RO RO96-02326A patent/RO113463B1/ro unknown
- 1995-05-31 JP JP50155696A patent/JP3575767B2/ja not_active Expired - Lifetime
- 1995-05-31 EP EP01200801A patent/EP1114821B1/en not_active Expired - Lifetime
- 1995-05-31 PT PT01200801T patent/PT1114821E/pt unknown
- 1995-05-31 DE DE69531801T patent/DE69531801T2/de not_active Expired - Lifetime
- 1995-05-31 ES ES01200801T patent/ES2207590T3/es not_active Expired - Lifetime
- 1995-05-31 BR BR9507980A patent/BR9507980A/pt not_active IP Right Cessation
- 1995-05-31 PL PL95317579A patent/PL188134B1/pl unknown
- 1995-05-31 SI SI9530691T patent/SI1114821T1/xx unknown
- 1995-05-31 AP APAP/P/1996/000889A patent/AP714A/en active
- 1995-05-31 ES ES95921798T patent/ES2170798T3/es not_active Expired - Lifetime
- 1995-05-31 CN CNB01124366XA patent/CN1234702C/zh not_active Expired - Lifetime
- 1995-05-31 DE DE69524871T patent/DE69524871T2/de not_active Expired - Lifetime
- 1995-05-31 KR KR1019960707048A patent/KR100397721B1/ko not_active Expired - Lifetime
- 1995-05-31 WO PCT/EP1995/002076 patent/WO1995034545A1/en not_active Ceased
- 1995-06-02 US US08/460,151 patent/US5760074A/en not_active Expired - Lifetime
-
1996
- 1996-12-09 NO NO19965260A patent/NO315651B1/no not_active IP Right Cessation
- 1996-12-10 FI FI964936A patent/FI120686B/fi not_active IP Right Cessation
- 1996-12-10 OA OA60933A patent/OA10593A/en unknown
- 1996-12-10 BG BG101040A patent/BG63339B1/bg unknown
-
2002
- 2002-01-10 HK HK02100192.4A patent/HK1039115B/en not_active IP Right Cessation
-
2003
- 2003-01-23 JP JP2003014984A patent/JP2003238554A/ja active Pending
-
2005
- 2005-03-15 CY CY0500017A patent/CY2508B1/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9406128A (pt) | Uso de um composto processo para o tratamento e/ou prevençao de distúrbios psicóticos composto composiçao farmacêutica processos para a preparaçao de um composto e de uma composiçao farmacêutica | |
| BR9507980A (pt) | Composto composição farmacêutica para uso no tratamento e/ou profilaxia de ansiedade mania depressão desordens associadas com uma hemorragia subaracnóide ou choke neural processo de tratamento e/ou profilaxia de ansiedade mania depressão desordens associadas com uma hemorragia subaracnóide ou choque neural composição farmacêutica uso de um composto | |
| BR9406566A (pt) | Composição farmacêutica uso de progesterona e/ou 17 - - estradiol e processo para a fabricação de uma preparação farmacêutica | |
| BR9407869A (pt) | Combinaçao composiçao farmacêutica e processo para o tratamento de osteoporose | |
| BR9509498A (pt) | Agente aglutinante uso do mesmo composição farmacêutica e processo para tratamento de uma doença inflamatória autoimune ou uma doença alérgica | |
| BR9407720A (pt) | Composto composiçao farmacêutica e processo para a prevençao ou tratamento de pertubaçoes imunorreguladoras ou doenças que compreendem a administraçao do composto | |
| BR9405911A (pt) | Processo para a preparaçao de uma composiçao de copolímero em bloco e composiçao de copolímero em bloco | |
| BR9705926A (pt) | Composição tópica utilização e processo para limitar diminuir e/ou impedir a transfêrencia de uma composição | |
| BR9609780A (pt) | Composto uso de um composto processo para o tratamento de condições composição farmacêutica processos para preparar uma composição farmacêutica e para preparar um composto | |
| IL122733A0 (en) | Pharmaceutical compositions for use in the treatment of allergic asthma | |
| BR9508586A (pt) | Compostos processo de preparação dos mesmos uso dos mesmos processo de tratamento de uma condição clínica em um mamífero e composição farmacêutica | |
| BR9301707A (pt) | Processo para incorporacao de um agente clarificador em uma resina poliolefina semi-cristalina e agente clarificador | |
| FI954654L (fi) | Aminosokeri- ja glykosaminoglykaanikoostumus sidekudosvauroiden hoitoon ja korjaukseen | |
| IL112029A (en) | Raloxifine and related compounds for use as medicaments for the treatment of disorders associated with an excess of tachykinin | |
| BR9709915A (pt) | Composto composição farmacêutica utilização do composto e processos para o tratamento ou a prevençao de distúrbios fisiológicos asociados com um excesso de taquiquininas e para preparação do composto | |
| BR9408148A (pt) | Processo para tratamento de arritmia composto e formulação farmacêutica | |
| EE9900607A (et) | Imidasopürimidiinid ja imidasopüridiinid neuroloogiliste häirete käitlemiseks | |
| BR9711108A (pt) | Compostos que sÆo novos derivados de piperidina 1,4- dissubstitu¡dos composi-Æo farmac-utica e processos para o tratamento ou profilaxia de doen-as associadas com receptores muscarinicos e para a prepara-Æo de derivados de piperidina 1,4- dissubstituidos contendo flÚor | |
| BR9612054A (pt) | Processo para a preparação de uma composição ou um componente detergente ou de limpeza granular e a (0) respectiva(0) composição ou componente | |
| BR9604894A (pt) | Derivado de acetamida processo para a preparação do mesmo e uma composição farmacêutica contendo o mesmo | |
| FI970920L (fi) | Trifenyylietyleenejä käytettäväksi osteoporoosin ehkäisyyn ja hoitoon | |
| BR9507788A (pt) | Composto ou solvato ou sal do mesmo processo para a preparação do composto composição farmacêutica antagonista do receptor de NK3 uso do composto uso do antagonista do receptor de NG3 e processo para o tratamento e/ou profilaxia de distúrbios pulmonares e distúrbios convulsivos | |
| BR9509989A (pt) | Processo para fabricar uma escova de abas abrasiva distribuidor de cobertura para utilização com o processo núcleo e escova de abas abrasivas | |
| BR9506581A (pt) | Composto composição farmacêutica uso do composto processo para a profilaxia ou tratamento de uma condição clínica em um manífero por exemplo um humano e para a preparação de um composto e composto intermediário | |
| BR9405216A (pt) | Processo para preparação de uma alcanona e/ou um alcanol |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB36 | Technical and formal requirements: requirement - article 36 of industrial property law | ||
| HJEG | Technical examination (opinion): technical examination (opinion) related to article 229 of industrial property law | ||
| FF | Decision: intention to grant | ||
| FG9A | Patent or certificate of addition granted | ||
| B21A | Patent or certificate of addition expired [chapter 21.1 patent gazette] |
Free format text: PATENTE EXTINTA EM 31/05/2015 |